2-(Aminoacylamino)benzophenones: Farnesyltransferase inhibition and antimalarial activity

Pharmazie

Volumn 60, Issue 9, 2005, Pages 677-682

  Kettler, K ^a   Wiesner, J ^b   Fucik, K ^a   Sakowski, J ^a   Ortmann, R ^a   Dahse, H M ^c   Jomaa, H ^b   Schlitzer, Martin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c HANS KNÖLL INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (AMINOACYLAMINO)BENZOPHENONE DERIVATIVE; AMINO ACID; BENZOPHENONE DERIVATIVE; N [2 BENZOYL 4 [3 [5 (4 NITROPHENYL) 2 FURYL]ACRYLOYLAMINO]PHENYL] 4 CHLOROPHENYLALANINAMIDE; N [2 BENZOYL 4 [3 [5 (4 NITROPHENYL) 2 FURYL]ACRYLOYLAMINO]PHENYL] 4 TRIFLUOROMETHYLPHENYLALANINAMIDE; N [2 BENZOYL 4 [3 [5 (4 NITROPHENYL) 2 FURYL]ACRYLOYLAMINO]PHENYL]LEUCINAMIDE; N [2 BENZOYL 4 [3 [5 (4 NITROPHENYL) 2 FURYL]ACRYLOYLAMINO]PHENYL]METHIONINAMIDE; N [2 BENZOYL 4 [3 [5 (4 NITROPHENYL) 2 FURYL]ACRYLOYLAMINO]PHENYL]PHENYLALANINAMIDE; N [2 BENZOYL 4 [3 [5 (4 NITROPHENYL) 2 FURYL]ACRYLOYLAMINO]PHENYL]TRYPTOPHANAMIDE; N [2 BENZOYL 4 [3 [5 (4 NITROPHENYL) 4 FURYL]ACRYLOYLAMINO]PHENYL]ISOLEUCINAMIDE; PROTEIN FARNESYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALARIA FALCIPARUM; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

AMINO ACIDS; ANIMALS; ANTIMALARIALS; BENZOPHENONES; ENZYME INHIBITORS; ERYTHROCYTES; ESCHERICHIA COLI; HELA CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PLASMODIUM FALCIPARUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 25144508486     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ancelin ML, Calas M, Bompart J, Cordina G, Martin D, Ban MB, Jei T, Druilhe P, Vial HJ (1998) Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. Blood 91: 1426-1437.
2. Chakrabarti D, Da Silva T, Barger J, Paquette S, Patel H, Patterson S, Allen CM (2002) Protein farnesyltransferase and protein prenylation in Plasmodium falciparum. J Biol Chem 277: 42066-42073.
3. Del Villar K, Mitsuzawa H, Yang W, Sattler I, Tamanoi F (1997) Amino acid substitutions that convert the protein substrat specificity of farnesyltransferase to that of geranylgeranyltransferase type I. J Biol Chem 272: 680-687.
4. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD (1979) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16: 710-718.
5. Fu H-W, Casey PJ (1999) Enzymology and biology of CaaX protein prenylation. Rec Prog Hormon Res 54: 315-343.
6. Keller O, Keller WE, van Look G, Wersin G In: Org. Synth. Freeman J P (ed.), York, 1990, Coll. Vol. VII, p. 70-75.
7. Kettler K, Sakowski J, Silber K, Sattler I, Klebe G, Schlitzer M (2003) Non-thiol farnesyltransferase inhibitors: N-(4-acylamino-3-benzoylphenyl)-3-[5- (4-nitrophenyl)-2-furyl]acrylic acid amides. Bioorg Med Chem 11: 1521-1530.
8. Kettler K, Wiesner J, Silber K, Haebel P, Ortmann R, Sattler I, Dahse H-M, Jomaa H, Klebe G, Schlitzer M (2004) Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl] acrylic acid amides and their antimalarial activity. Eur J Med Chem: in press
9. Pompliano DL, Gomez RP, Anthony NJ (1992) Intramolecular fluorescece enhancement: a continuous assay of Ras farnesyl: protein transferase. J Am Chem Soc 114: 7945-7946.
10. Ridley RG (2002) Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 415: 686-693.
11. Rijkers DTS, Adam HPHM, Hemker HC, Tesser GI (1995) A convenient synthesis for amino acid p-nitroanilides: synthons in the synthesis of protease substrates. Tetrahedron 51: 11235-11250.
12. Sachs J, Malaney P (2002) The economic and social burden of malaria. Nature 415: 680-685.
13. Sakowski J, Sattler I, Schlitzer M (2002) Non-thiol farnesyltransferase inhibitors: N-(4-acylamino-3-benzoylphenyl)-4-nitrocinnamic acid amides. Bioorg Med Chem 10: 233-239.
14. Schlitzer M (2002) Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors. Curr Pharm Design 8: 1713-1722.
15. Trager W, Jensen JB (1976) Human malaria parasites in continous culture. Science 193: 673-675.
16. Wiesner J, Kettler K, Sakowski J, Ortmann R, Jomaa H, Schlitzer M (2003a) Structure-activity relationships of novel anti-malarial agents: 5. N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides. Bioorg Med Chem Lett 13: 361-363.
17. Wiesner J, Fucik K, Kettler K, Sakowski J, Ortmann R, Jomaa H, Schlitzer M (2003b) Structure-activity relationships of novel anti-malarial agents: 6. N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides. Bioorg Med Chem Lett 13: 1539-1541.
18. Wiesner J, Kettler K, Sakowski J, Ortmann R, Katzin AM, Kimura EA, Silber K, Klebe G, Jomaa H, Schlitzer M (2004) Farnesyltransferase inhibitors inhibit the growth of Malaria parasites in vitro and in vivo. Angew Chem Int Ed 43: 251-254.
19. Wittinghofer A, Waldmann H (2000) Ras - a molecular switch involved in tumor formation. Angew Chem Int Ed 39: 4192-4214.